Search results
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 6 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 7 days agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 7 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 6 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 7 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around $0.3bn in net sales for the first half of the...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 7 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 7 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 7 days agoStrategic Developments and Future Outlook Moderna's CEO, Stephane Bancel, emphasized the company's...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 6 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...